Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Jan 2010 18:17

RNS Number : 5208F
Skyepharma PLC
13 January 2010
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

SkyePharma Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

Delta adjustment

 X

3. Full name of person(s) subject to the notification obligation:

D.E. Shaw & Co., L.P. D.E. Shaw & Co. (U.K.), Ltd.

4. Full name of shareholder(s) (if different from 3.):

 N/A

5. Date of the transaction and date on which the threshold is crossed or reached:

 January 11, 2010

6. Date on which issuer notified:

 January 13, 2010

7. Threshold(s) that is/are crossed or reached:

 32%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 

 

 

 

 

 

 

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
 
Type of financial instrument
Exercise price
Expiration date
Exercise/ Conversion period
Number of voting rights instrument refers to
% of voting rights
 
Contract for Differences ("CfD") relating to convertible bond due 2024
 
March 4, 2010
 
3,461,725
Nominal
Delta 
 
14.46%
CfD relating to convertible bond due 2025
 
December 3, 2010
 
2,058,916
Nominal
Delta
 
8.60%
CfD relating to convertible bond due 2025
 
June 3, 2010
 
 2,058,916
Nominal
Delta
 
 8.60%

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

7,579,557

 

31.66%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Each of D.E. Shaw & Co., L.P. ("DESCO LP") and D.E. Shaw & Co. (U.K.), Ltd. ("DESCO UK") is notifying solely in its capacity as a discretionary investment manager. As general partner of DESCO LP, D.E. Shaw & Co., Inc. ("DESCO Inc.") is a parent undertaking of DESCO LP and DESCO UK. By virtue of David E. Shaw's position as president and sole shareholder of DESCO, Inc., which is the general partner of DESCO LP, David E. Shaw is a parent undertaking of DESCO LP and DESCO UK.

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

 

14. Contact name:

Stephen Back (Compliance Department)

15. Contact telephone number:

+1 212-478-0000 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDXLFFBFFLBBD
Date   Source Headline
31st May 20131:01 pmRNSHolding(s) in Company
21st May 20134:49 pmRNSHolding(s) in Company
21st May 20131:52 pmRNSHolding(s) in Company
21st May 201310:13 amRNSHolding(s) in Company
14th May 201312:35 pmRNSHolding(s) in Company
13th May 20137:00 amRNSBREO ELLIPTA Receives Regulatory Approval in U.S.
9th May 20131:08 pmRNSResult of AGM
9th May 20137:00 amRNSInterim Management Statement
3rd May 201311:31 amRNSDirector/PDMR Shareholding
11th Apr 20134:24 pmRNSAnnual Financial Report
5th Apr 20133:34 pmRNSDirector/PDMR Shareholding
3rd Apr 20133:06 pmRNSDirector/PDMR Shareholding
28th Mar 20133:47 pmRNSDirector/PDMR Shareholding
26th Mar 20132:06 pmRNSHolding(s) in Company
21st Mar 20137:00 amRNSFinal Results
18th Mar 201312:37 pmRNSHolding(s) in Company
15th Mar 20139:41 amRNSHolding(s) in Company
6th Mar 201311:41 amRNSDirector/PDMR Shareholding
5th Mar 201310:55 amRNSNotice of Results
13th Feb 20139:47 amRNSDirector/PDMR Shareholding
6th Feb 20134:58 pmRNSDirector/PDMR Shareholding
5th Feb 201310:23 amRNSHolding(s) in Company
8th Jan 20132:50 pmRNSHolding(s) in Company
4th Jan 20134:03 pmRNSDirector/PDMR Shareholding
21st Dec 20124:23 pmRNSDirector/PDMR Shareholding
21st Dec 20124:22 pmRNSDirector/PDMR Shareholding
21st Dec 201212:18 pmRNSDirector/PDMR Shareholding
21st Dec 201211:48 amRNSResult of EGM
18th Dec 20127:00 amRNSYear End Update
5th Dec 201211:37 amRNSDirector/PDMR Shareholding
30th Nov 20123:27 pmRNSMiscellaneous re SkyePharma (Jersey) Ltd
29th Nov 20129:34 amRNSHolding(s) in Company
28th Nov 20125:36 pmRNSNotice of EGM
21st Nov 201210:05 amRNSHolding(s) in Company
6th Nov 20125:58 pmRNSHolding(s) in Company
6th Nov 20125:18 pmRNSDirector/PDMR Shareholding
15th Oct 20127:00 amRNSInterim Management Statement
5th Oct 20124:44 pmRNSHolding(s) in Company
4th Oct 20122:27 pmRNSHolding(s) in Company
3rd Oct 20125:35 pmRNSDirector/PDMR Shareholding
3rd Oct 20124:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20124:35 pmRNSPrice Monitoring Extension
28th Sep 201210:57 amRNSHolding(s) in Company
28th Sep 20127:00 amRNSAmendment to CRC Finance Facility
27th Sep 20124:33 pmRNSHolding(s) in Company
27th Sep 20129:28 amRNSHolding(s) in Company
26th Sep 20123:48 pmRNSHolding(s) in Company
26th Sep 20122:51 pmRNSHolding(s) in Company
26th Sep 201211:48 amRNSHolding(s) in Company
26th Sep 201211:19 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.